Lb Pharmaceuticals

(NASDAQ) LBRX

Current Price$32.10

Market Cap$912.72M

Since IPO (2025)+82%

5 YearN/A

1 YearN/A

1 Month+24%

Lb Pharmaceuticals Financials at a Glance

Market Cap

$912.72M

Revenue (TTM)

$0.00

Net Income (TTM)

$25.20M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

1.05 (Average)

Dividend

$0.00

Beta (Volatility)

1.05 (Average)

Price

$32.10

Volume

6,306.826

Open

$32.07

Price

$32.10

Volume

6,306.826

Open

$32.07

Previous Close

$31.83

Daily Range

$31.96 - $32.75

52-Week Range

$13.36 - $33.47

Dividend

$0.00

Beta (Volatility)

1.05 (Average)

Price

$32.10

Volume

6,306.826

Open

$32.07

Previous Close

$31.83

Daily Range

$31.96 - $32.75

52-Week Range

$13.36 - $33.47

LBRX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lb Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Heather D. Turner

Website

www.lbpharma.us

Headquarters

New York, NY 10119, US

LBRX Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

-10%

Return on Assets

-8%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$912.72M

Shares Outstanding

28.67M

Volume

6.31K

Avg. Volume

259.94K

Financials (TTM)

Gross Profit

$321.00K

Operating Income

$30.40M

EBITDA

$30.08M

Operating Cash Flow

$35.21M

Capital Expenditure

$52.00K

Free Cash Flow

$35.26M

Cash & ST Invst.

$295.21M

Total Debt

$3.57M

Lb Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$85.00K

-1600.0%

Gross Margin

0.00%

N/A

Market Cap

$912.72M

N/A

Market Cap/Employee

$57.04M

N/A

Employees

N/A

Net Income

$11.47M

+19.1%

EBITDA

$13.79M

+2.8%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$291.64M

+304.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$2.84M

N/A

Short Term Debt

$730.00K

N/A

Return on Assets

-8.05%

N/A

Return on Invested Capital

-9.95%

N/A

Free Cash Flow

$18.14M

+19.3%

Operating Cash Flow

$18.10M

+17.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

DSGNDesign Therapeutics, Inc.

DSGNDesign Therapeutics, Inc.$13.21+0.27%

ANNXAnnexon, Inc.

ANNXAnnexon, Inc.$5.74+0.96%

AURAAura Biosciences, Inc.

AURAAura Biosciences, Inc.$9.19+10.06%

SLDBSolid Biosciences Inc.

SLDBSolid Biosciences Inc.$7.12-1.52%

DBVTDBV Technologies S.A.

DBVTDBV Technologies S.A.$19.80+1.69%

AUTLAutolus Therapeutics plc

AUTLAutolus Therapeutics plc$1.64+4.46%

RCKTRocket Pharmaceuticals, Inc.

RCKTRocket Pharmaceuticals, Inc.$3.58-0.69%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.64+0.04%

CIFRCipher Mining

CIFRCipher Mining$19.30+0.08%

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF

CONLGraniteShares ETF Trust - GraniteShares 2x Long Coin Daily ETF$8.56-0.05%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$46.06+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$48.79-0.03%

PUMPProPetro

PUMPProPetro$16.97+0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.00%

Questions About LBRX

What is the current price of Lb Pharmaceuticals?

Lb Pharmaceuticals is trading at $32.11 per share.

What is the 52-week range for Lb Pharmaceuticals?

Over the past 52 weeks, Lb Pharmaceuticals has traded between $13.36 and $33.47.

How much debt does Lb Pharmaceuticals have?

As of the most recent reporting period, Lb Pharmaceuticals reported total debt of $3.57M.

How much cash does Lb Pharmaceuticals have on hand?

Lb Pharmaceuticals reported $250.17M in cash and cash equivalents in its most recent financial results.

What is Lb Pharmaceuticals’s dividend yield?

Lb Pharmaceuticals does not currently have a dividend yield.

Lb Pharmaceuticals

Lb Pharmaceuticals Financials at a Glance

LBRX News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lb Pharmaceuticals

LBRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lb Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LBRX

What is the current price of Lb Pharmaceuticals?

What is the 52-week range for Lb Pharmaceuticals?

How much debt does Lb Pharmaceuticals have?

How much cash does Lb Pharmaceuticals have on hand?

What is Lb Pharmaceuticals’s dividend yield?

Premium Investing Services